Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term MUTATIONS. Found 24 abstracts

no pagination
Ibragimova I, Dulaimi E, Slifker MJ, Chen DY, Uzzo RG, Cairns P. A global profile of gene promoter methylation in treatment-naive urothelial cancer. Epigenetics. 2014 May;9(5):760-73.   PMCID: Pmc4063835
Pei JM, Robu V, Feder M, Cheung M, Neumann-Domer E, Talarchek J, Dulaimi E, Millenson MM, Testa JR. Copy neutral loss of heterozygosity in 20q in chronic lymphocytic leukemia/small lymphocytic lymphoma. Cancer Genetics. 2014 Mar;207(3):98-102.
von Mehren M, Randall RL, Benjamin RS, Boles S, Bui MM, Casper ES, Conrad EU, DeLaney TF, Ganjoo KN, George S, Gonzalez RJ, Heslin MJ, Kane JM, Mayerson J, McGarry SV, Meyer C, O'Donnell RJ, Pappo AS, Paz IB, Pfeifer JD, Riedel RF, Schuetze S, Schupak KD, Schwartz HS, Van Tine BA, Wayne JD, Bergman MA, Sundar H. Soft Tissue Sarcoma, Version 2.2014 Featured Updates to the NCCN Guidelines. Journal of the National Comprehensive Cancer Network. 2014 Apr;12(4):473-83.   PMCID: No NIH funds
DeMatteo RP, Ballman KV, Antonescu CR, Maki RG, Pisters PW, Demetri GD, Blackstein ME, Blanke CD, von Mehren M, Brennan MF, Patel S, McCarter MD, Polikoff JA, Tan BR, Owzar K, ACOSOG Intergrp Adjuvant GIST Stud. Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal stromal tumour: a randomised, double-blind, placebo-controlled trial. Lancet (London, England). 2009 Mar;373(9669):1097-104.   PMCID: PMC2915459
Fang CY, Cherry C, Devarajan K, Li TY, Malick J, Daly MB. A prospective study of quality of life among women undergoing risk-reducing salpingo-oophorectomy versus gynecologic screening for ovarian cancer. Gynecologic Oncology. 2009 Mar;112(3):594-600.   PMCID: PMC2697574
Howard JH, Frolov A, Tzeng CW, Stewart A, Midzak A, Majmundar A, Godwin AK, Heslin MJ, Bellacosa A, Arnoletti P. Epigenetic downregulation of the DNA repair gene MED1/MBD4 in colorectal and ovarian cancer. Cancer Biology & Therapy. 2009 Jan;8(1):94-100.   PMCID: PMC2683899
Pimkin M, Pimkina J, Markham GD. A Regulatory Role of the Bateman Domain of IMP Dehydrogenase in Adenylate Nucleotide Biosynthesis. Journal of Biological Chemistry. 2009 Mar;284(12):7957-66.   PMCID: PMC2658089
Sykes SM, Stanek TJ, Frank A, Murphy ME, McMahon SB. Acetylation of the DNA Binding Domain Regulates Transcription-independent Apoptosis by p53. Journal of Biological Chemistry. 2009 Jul;284(30):20197-205.   PMCID: PMC 2740446
Blanke CD, Demetri GD, von Mehren M, Heinrich MC, Eisenberg B, Fletcher JA, Corless CL, Fletcher CD, Roberts PJ, Heinz D, Wehre E, Nikolova Z, Joensuu H. Long-term results from a randomized phase II trial of standard- versus higher-dose imatinib mesylate for patients with unresectable or metastatic gastrointestinal stromal tumors expressing KIT. Journal of Clinical Oncology. 2008 Feb;26(4):620-5.
Blanke CD, Rankin C, Demetri GD, Ryan CW, von Mehren M, Benjamin RS, Raymond AK, Bramwell VH, Baker LH, Maki RG, Tanaka M, Hecht JR, Heinrich MC, Fletcher CD, Crowley JJ, Borden EC. Phase III randomized, intergroup trial assessing imatinib mesylate at two dose levels in patients with unresectable or metastatic gastrointestinal stromal tumors expressing the kit receptor tyrosine kinase: S0033. Journal of Clinical Oncology. 2008 Feb;26(4):626-32.
Majtan T, Singh LR, Wang LQ, Kruger WD, Kraus JP. Active Cystathionine beta-Synthase Can Be Expressed in Heme-free Systems in the Presence of Metal-substituted Porphyrins or a Chemical Chaperone. Journal of Biological Chemistry. 2008 Dec;283(50):34588-95.
Carvalho MA, Marsillac SM, Karchin R, Manoukian S, Grist S, Swabym RF, Urmenyi TP, Rondinelli E, Silva R, Gayol L, Baumbach L, Sutphen R, Pickard-Brzosowicz JL, Nathanson KL, Sali A, Goldgar D, Couch FJ, Radice P, Monteiro AN. Determination of cancer risk associated with germ line BRCA1 missense variants by functional analysis. Cancer Research. 2007 Feb;67(4):1494-501.
Li H, Cherukuri P, Li N, Cowling V, Spinella M, Cole M, Godwin AK, Wells W, DiRenzo J. Nestin is expressed in the basal/myoepithelial layer of the mammary gland and is a selective marker of basal epithelial breast tumors. Cancer Research. 2007 Jan;67(2):501-10.
Mellert H, Sykes SM, Murphy ME, McMahon SB. The ARF/oncogene pathway activates p53 acetylation within the DNA binding domain. Cell cycle (Georgetown, Tex). 2007 Jun;6(11):1304-6.
Mello ML, Vidal BC, Russo IH, Lareef MH, Russo J. DNA content and chromatin texture of human breast epithelial cells transformed with 17-beta-estradiol and the estrogen antagonist ICI 182,780 as assessed by image analysis. Mutation Research-Fundamental and Molecular Mechanisms of Mutagenesis. 2007 Apr;617(1-2):1-7.
Pakkanen S, Baffoe-Bonnie AB, Matikainen MP, Koivisto PA, Tammela TL, Deshmukh S, Ou L, Bailey-Wilson JE, Schleutker J. Segregation analysis of 1,546 prostate cancer families in Finland shows recessive inheritance. Human Genetics. 2007 Apr;121(2):257-67.
Singh RH, Kruger WD, Wang LQ, Pasquali M, Elsas LJ. Cystathionine beta-synthase deficiency: Effects of betaine supplementation after methionine restriction in B6-nonresponsive homocystinuria. Genetics in Medicine. 2004 Mar;6(2):90-5.
Wang LQ, Jhee KH, Hua X, DiBello PM, Jacobsen DW, Kruger WD. Modulation of cystathionine beta-synthase level regulates total serum homocysteine in mice. Circulation research. 2004 May;94(10):1318-24.
Kruger WD, Wang L, Jhee KH, Singh RH, Elsas LJ. Cystathionine beta-synthase deficiency in Georgia (USA): Correlation of clinical and biochemical phenotype with genotype. Human Mutation. 2003 Dec;22(6):434-41.
Drummond JT, Bellacosa A. Human DNA mismatch repair in vitro operates independently of methylation status at CpG sites. Nucleic acids research. 2001 Jun;29(11):2234-43.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term MUTATIONS

MUTATIONS GENE SURVIVAL KeyWords Plus: PROGNOSTIC-FACTORS P53-DEPENDENT APOPTOSIS CANCER YEAST homocystinuria INHIBITOR C-KIT DEFICIENCY Oncology MOLECULAR-BASIS MED1 MBD4 TRANSSULFURATION PROGRESSION RISK Genetics & Heredity INSTABILITY LINE MICROSATELLITE PLASMA HOMOCYSTEINE SPECIFICITY PYRIDOXINE PSYCHOLOGICAL IMPACT Chronic lymphocytic leukemia ESCHERICHIA-COLI MENOPAUSE LIGAND SWITCH Screening P53 HOMOLOG GENOTYPE PEDIGREE DATA NUCLEIC-ACID BINDING OVARIAN-CANCER MYC methylation AUTOSOMAL-DOMINANT INHERITANCE yeast STI571 N-GLYCOSYLASE HEREDITARY ACTIVATION RESISTANCE TERMINAL REGION BRCA2 p19ARF mutation analysis ESCHERICHIA-COLI K-12 PREVENTION RECURRENT GENOMIC ALTERATIONS METAPHASE RETROPERITONEAL SARCOMA PHOSPHOPEPTIDE RECOGNITION STEM-CELLS CDKN2A DISEASE GERMLINE MUTATIONS imprinting apoptosis MALIGNANCIES PHASE-III Biochemistry & Molecular Biology NEOPLASTIC TRANSFORMATION INDUCTION P53 DEATH TRIAL ABDOMINAL HYSTERECTOMY transitional cell carcinoma genotype-phenotype correlation DOMAIN cystathionine beta-synthase ALZHEIMERS-DISEASE CIMP FAMILIAL ADENOMATOUS POLYPOSIS PREVALENCE metabolism ovarian cancer POOR-PROGNOSIS GERMLINE amino acids MED1 BACH1 PHOSPHOPEPTIDE KIT SALMONELLA-TYPHIMURIUM LINE P53 INTERMEDIATE FILAMENT PROTEIN MCF-10 acetylation Ovarian cancer REPLICATION FIDELITY TIP60 GROWTH ENDOTHELIAL-CELLS PHOSPHORYLATION TRANSCRIPTIONAL ACTIVATION MANAGEMENT DEFICIENT MICE PROPHYLACTIC OOPHORECTOMY ARRAY ELECTRON-BEAM RADIOTHERAPY DNA-SEQUENCE VARIANTS FOLIC-ACID SUPPLEMENTATION DOMINANT RETINITIS-PIGMENTOSA ENDOTHELIAL DYSFUNCTION CLINICAL PHENOTYPE EARLY-STAGE betaine therapy chromosome microarray analysis HOMOCYSTEINE ST1571 TP53 DNA METHYLATION bladder cancer colorectal cancer MYELODYSPLASTIC SYNDROMES SURGICAL ADJUVANT BREAST MITOCHONDRIA TYROSINE KINASE genetics CARNEY-STRATAKIS CEREBROSPINAL-FLUID UNKNOWN CLINICAL-SIGNIFICANCE CELL CARCINOMA SARCOMA-GROUP ISLAND METHYLATOR PHENOTYPE ONSET p53 EFFICACY PHENOTYPE HYPERHOMOCYSTEINEMIA GLYCOSYLASE MBD4 HMLH1 HUMAN COLON cardiovascular diseases MDM2 CARCINOMA SUBSTRATE 17-beta-estradiol human breast epithelial cells-benzo[a]pyrene-ICI 182-780-DNA content-chromatin supraorganization ADENOSYL-L-METHIONINE RADIATION-THERAPY urothelial carcinoma HYPERMETHYLATION B6-nonresponsive BLADDER-CANCER IN-VITRO PROMOTER HYPERMETHYLATION INK4A
Last updated on Thursday, April 02, 2020